المؤلفون: AL-Suraify, Sajida Munadi Th.^{Aff1, IDs13204021020803_cor1}, Hussien, Lamees Bassim

المصدر: Applied Nanoscience. 13(3):2083-2092

المؤلفون: Lu, Feipeng^Aff3, Li, Shenghua^Aff4, Chen, Jianhua^Aff3, He, Aifeng^Aff3, Wang, Yin^Aff3

المساهمون: Gany, Alon, editor^Aff1, Fu, Xiaolong, editor^Aff2

المصدر: 2021 International Conference on Development and Application of Carbon Nanomaterials in Energetic Materials. 276:481-493

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Zeng, S., Dou, W., Li, M., Zhou, Yang, 1989, Guo, J., Zhao, N., Huang, H., Zhou, Q., Hu, W., Ma, Y., Zhao, X., Xie, H.

المصدر: ChemMedChem. 15(16):1608-1617

مصطلحات موضوعية: biostability, DPP-IV, in silico testing, inhibitors, metabolism, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 (1h pyrazol 4 yl)thieno[3, 2 d]pyrimidin 3(4h) yl]methyl] 4 fluorobenzonitrile, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 (pyridin 3 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 (pyridin 4 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 [3 (trifluoromethyl)phenyl]thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 7 (pyridin 3 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (2 methoxypyridin 4 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (2 methylpyridin 4 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (3 fluorophenyl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (3, 5 dimethylisoxazol 4 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (4 fluorophenyl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 bromo 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 [3 (methylsulfonyl)phenyl] 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 bromo 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 fluoro 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 methyl 4 oxo 6 (pyridin 3 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 methyl 4 oxothieno[3, antidiabetic agent, cytochrome P450, dipeptidyl peptidase IV inhibitor, long acting drug, pyrimidine derivative, trelagliptin, unclassified drug, xanthine derivative, animal experiment, area under the curve, Article, computer model, controlled study, drug bioavailability, drug design, drug efficacy, drug half life, drug potency, drug transformation, glycemic control, IC50, in vitro study, in vivo study, infant, male, maximum plasma concentration, mean residence time, metabolic stability, nonhuman, priority journal, rat, time to maximum plasma concentration

وصف الملف: print

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-286487
https://doi.org/10.1002/cmdc.202000175

المؤلفون: Abushamleh, A. S.^Aff1, Abu-Safieh, K. A., Khanfar, M. A., Taher, D., Tahtamouni, L., Alwahsh, N. J.

المصدر: Journal of Structural Chemistry. 62(7):1112-1122

المؤلفون: Pardasani, R. T.^Aff10, Pardasani, P.^Aff20

المساهمون: Pardasani, R. T.^Aff1, Pardasani, P.^Aff2, Gupta, A., editor^Aff3

المصدر: Magnetic Properties of Paramagnetic Compounds, Magnetic Susceptibility Data, Volume 4 : A Supplement to Landolt-Börnstein II/31 Series. :1303-1305

المؤلفون: Shaimaa Mohsen. Essa, Wisam Hindawi Hoidy

المصدر: Nano Biomedicine and Engineering, Vol 12, Iss 2, Pp 160-166 (2020)

مصطلحات موضوعية: heterocyclic, pyrazol, azo, antipyrene, antimicrobial, antioxidants, Biology (General), QH301-705.5, Medicine

وصف الملف: electronic resource

Relation: https://www.sciopen.com/article/10.5101/nbe.v12i2.p160-166; https://doaj.org/toc/2150-5578

URL الوصول: https://doaj.org/article/0934273f5c5c4818a015cdc41bef7a80

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Ahmadian, Fatemeh, Barmak, Alireza, Ghaderi, Esmali, Bavadi, Masoumeh, Raanaei, Hossein, Niknam, Khodabakhsh^Aff1

المصدر: Journal of the Iranian Chemical Society. 16(12):2647-2658

المؤلفون: Gandhi, Sahaj A.^Aff1, Patel, Urmila H., Barot, V. M., Varma, N. V. S.

المصدر: Indian Journal of Physics. 93(10):1275-1291